Adial Pharmaceuticals Inc Common Stock (ADIL)

About ADIL

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and oth…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

5

Website

www.adialpharma.com/

Fundamentals

1-day range

$3.7$4.87

Market cap

$10.29M

P/E (trailing)

—

P/E (forward)

-0.53

EPS (trailing)

$-9.93

Dividend yield

—

Beta

-394.72

Avg. volume

459.1K

Forecasts

3 analyst ratings

Adial Pharmaceuticals Inc Common Stock Competitors

Chosen by industry and closest market cap.

• ADIL

  Adial Pharmaceuticals Inc Common Stock

  $5.6

  ▼ 1.41%
  Market cap $10.29MP/E —
  $1.31$249.81
• TOVX

  Theriva Biologics Inc. Common Stock

  $0.247

  ▼ 1.20%
  Market cap $10.32MP/E —
  $0.1628$0.8632
• BFRG

  Bullfrog AI Holdings Inc. Common Stock

  $0.54

  ▼ 4.49%
  Market cap $10.96MP/E —
  $0.4251$2.04
• GDTC

  CytoMed Therapeutics Limited Ordinary Shares

  $0.92

  ▼ 4.17%
  Market cap $9.50MP/E —
  $0.6801$3.68
• QNRX

  Quoin Pharmaceuticals Ltd. American Depositary Shares

  $6.13

  ▲ 18.91%
  Market cap $9.18MP/E —
  $3.25$41.8
• LEXX

  Lexaria Bioscience Corp. Common Stock

  $10.35

  ▼ 11.39%
  Market cap $8.82MP/E —
  $4.21$23.25
• XCUR

  Exicure Inc. Common Stock

  $1.34

  ▼ 5.32%
  Market cap $8.60MP/E —
  $1.05$9.48

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Adial Pharmaceuticals Files Prospectus Related To The Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders
  benzinga · 8/28/2026
• Adial Pharmaceuticals Files Prospectus Related To The Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders
  Benzinga · 8/28/2026
• 12 Health Care Stocks Moving In Monday's Intraday Session
  Benzinga · 8/24/2026
• These stocks are moving in today's pre-market session
  ChartMill · 8/17/2026
• 12 Health Care Stocks Moving In Monday's Pre-Market Session
  Benzinga · 8/17/2026
• Adial Pharmaceuticals Says As Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting; Anticipates Matthew Davidson To Be Appointed President And CEO; Anticipates Termination Of CFO Vinay Shah After 2026 Annual Meeting; Anticipates Board Changes And Legacy Member Resignations
  Benzinga · 8/13/2026

• Coastlands Capital LP · July 16, 2026 · Buy

  1.2K @ $2.75
• Coastlands Capital LP · July 14, 2026 · Buy

  2.0K @ $2.65
• Coastlands Capital LP · July 10, 2026 · Buy

  1.7K @ $2.7
• Coastlands Capital LP · July 9, 2026 · Buy

  10.1K @ $2.79
• Coastlands Capital LP · June 29, 2026 · Buy

  25.0K @ $2.6
• Matt Davidson · June 12, 2026 · Grant

  232.4K
• Young Wendy B. · June 12, 2026 · Buy

  36.4K @ $2.75
• Matt Davidson · June 11, 2026 · Grant

  101
• Matt Davidson · June 11, 2026 · Grant

  1.8K
• Matt Davidson · June 11, 2026 · Grant

  3.4K
• Matt Davidson · June 11, 2026 · Grant

  61.6K
• Anderson J. Kermit · April 7, 2026 · Grant

  9.2K
• Tony Goodman · April 7, 2026 · Grant

  26.5K
• Vinay Shah · April 7, 2026 · Grant

  17.3K
• Kevin Schuyler · April 7, 2026 · Grant

  9.2K

Institutional Ownership

March 31, 2026

Total shares held

29.7K

Total value held

$53.1K

Institutional holders

13